Human Identification Market

The human identification market is valued at an estimated USD 0.8 billion in 2024 and is projected to reach USD 1.3 billion by 2029 at a CAGR of 10.7% during the forecast period. The growth of this market is mainly driven by government initiatives for forensic programs, increasing demand for paternity testing, rise in crime rates, market expansion initiatives by key players, and the rising awareness among investigators about the role of DNA profiling in criminology.

The key players in human identification market are Thermo Fisher Scientific Inc. (US), QIAGEN N.V. (Netherlands), Promega Corporation (US), Hamilton Company (US), FUJIFILM Wako Pure Chemical Corporation (Japan), ANDE (US), AutoGen Inc. (US), InnoGenomics Technologies, LLC (US), Oxford Nanopore Technologies Plc (UK), Bode Cellmark Forensics Inc. (US), Carolina Biological Supply (US), Genetek Biopharma GmbH (Germany), STRmix Limited (New Zealand), Ningbo HEALTH Gene Technologies Co., Ltd. (China), SoftGenetics (US), JusticeTrax (US), Geno Technology, Inc.(US), Bio-Rad Laboratories, Inc. (US), Complete Genomics (US), Bioneer Corporation (Republic of Korea), Abnova Corporation (Taiwan), and ZEISS (Germany).

To know about the assumptions considered for the study download the pdf brochure

In 2023, Thermo Fisher Scientific Inc. (US) accounted for highest share of the human identification market in 2023. The company has a broad product portfolio and caters to different HID applications. For instance, in 2021, the company’s Rapid DNA Solution was greenlit by the FBI for deployment in law enforcement booking stations, marking a significant advancement in DNA processing technology’s integration into criminal identification procedures. Similarly, the 2024 event hosted by Thermo Fisher for Human Identification Solutions (HIDS) highlights its innovative leadership in the human identification market, nurturing collaboration and innovation at the forefront of forensic science.

In 2023, QIAGEN N.V. (Netherlands) accounted for the second-largest share of the human identification market in 2023. The company offers human identification consumables and instruments and possesses a competitive edge in the human identification market by leveraging its extensive array of sophisticated technologies, enabling accurate and efficient DNA analysis for forensic applications. It focuses on organic and inorganic strategies to strengthen its position in the human identification market. In 2023, QIAGEN finalized the acquisition of Verogen (US), a frontrunner in leveraging NGS technologies in HID and forensic inquiries.

In 2023, Promega Corporation (US) accounted for the third-largest share of the human identification market in 2023. It offers a comprehensive portfolio of reagents, instrumentation, and support services for DNA extraction, quantification, and STR amplification, as well as analysis through capillary electrophoresis and massively parallel sequencing techniques. The company focuses on organic growth strategies such as product launches. In 2023, the company launched the PowerPlex 35GY System, a novel DNA analysis chemistry, empowering forensic labs to surmount obstacles posed by degraded and contaminated samples, marking a pivotal advancement in forensic DNA analysis.

Related Reports:

Human Identification Market by Product (Consumables (Kits & Reagents), Instruments, Software), Technology (PCR, Capillary Electrophoresis, Microarrays, NGS, Rapid DNA), Application (Forensics, Paternity Testing), End User - Global Forecasts to 2029

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]